Print Page | Sign In | Join
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Displaying page 26 of 27
 |<   <<   <  21  |  22  |  23  |  24  |  25  |  26  |  27

Scientific Advancements
Friday, April 14, 2017   (0 Comments - view/add)
OBMedical Company Announces LABORVIEW® now available for Hospitals using Philips Fetal Monitoring Eq »
FOR IMMEDIATE RELEASE OBMedical Company Announces LABORVIEW® now available for Hospitals using Philips Fetal Monitor...
Tuesday, February 28, 2017   (0 Comments - view/add)
Mayo Clinic publishes genetic screen for Alzheimer's in African-Americans »
February 28, 2017   Mayo Clinic publishes genetic screen for Alzheimer's in African-Americans &nbs...
Monday, February 20, 2017   (0 Comments - view/add)
Stem Cell Company Combining Stem Cell Therapy with Hyperbaric Oxygen Treatment »
Stem Cell Company Combining Stem Cell Therapy with Hyperbaric Oxygen Treatment TAMPA, Fla. , Feb. 20, 2017 /PRNewswi...
Thursday, February 9, 2017   (0 Comments - view/add)
Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion »
Prevacus to Begin Phase 1 Clinical Studies of PRV-002 for the Treatment of Concussion February 14, 2017 TALLAHASS...
Wednesday, February 1, 2017   (0 Comments - view/add)
Mayo Clinic to test vaccine designed to provide immune response against early breast lesions »
For additional news and information, visit: Mayo Clinic News Network ....
Tuesday, January 31, 2017   (0 Comments - view/add)
Morphogenesis Announces Issuance of US Patent for Cancer Vaccines under Expedited Cancer Moonshot Im »
Morphogenesis Announces Issuance of US Patent for Cancer Vaccines under Expedited Cancer Moonshot Immunotherapy Program...
Tuesday, January 10, 2017   (0 Comments - view/add)
TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients »
TapImmune Launches Phase 2 Ovarian Cancer Trial In Platinum-Sensitive Patients Company-Sponsored Ovarian Cancer Trial H...
Wednesday, December 14, 2016   (0 Comments - view/add)
Natural kill cell technology to stop cancer gets licensed »
Natural kill cell technology to stop cancer gets licensed December 14, 2016 University of Centra...
Monday, December 5, 2016   (0 Comments - view/add)
TherapeuticsMD Announces Positive Top-Line Results from Pivotal Phase 3 Replenish Trial in Postmenop »
TherapeuticsMD Announces Positive Top-Line Results from Pivotal Phase 3 Replenish Trial in Postmenopausal Women with Moder...
Tuesday, November 1, 2016   (0 Comments - view/add)
TapImmune Announces Commercialization Pathway For Its HER2neu Vaccine »
TapImmune Announces Commercialization Pathway For Its HER2neu Vaccine Initiation of Company-Sponsored Phase 2 Clinical...
Thursday, October 27, 2016   (0 Comments - view/add)
Quorum Innovations Advances Human Microbiome Program »
Quorum Innovations Advances Human Microbiome Program U.S. Patent allowance for Method of identifying a biologically - a...
Thursday, October 20, 2016   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Further Positive Interim Data in its Phase II(b) Cancer Trial »
HedgePath Pharmaceuticals Announces Further Positive Interim Data in its Phase II(b) Cancer Trial 18 subjects with Basa...
Thursday, October 20, 2016   (0 Comments - view/add)
VICC trial putting lung cancer therapy to the test »
VICC trial putting lung cancer therapy to the test   by Dagny Stuart | Thursday, Oct. 20, 2016, 8:41 AM...
Tuesday, October 4, 2016   (0 Comments - view/add)
Somahlution Announces Study Results Showing DuraGraft® Vascular Graft Treatment Improves Long-Term O »
Somahlution Announces Study Results Showing DuraGraft® Vascular Graft Treatment Improves Long-Term Outcomes in Coronary Ar...
Tuesday, October 4, 2016   (0 Comments - view/add)
Asana Medical, Inc.'s Preclinical Study Indicates Promising Solution to Treat Ulcerative Colitis »
Asana Medical, Inc.'s Preclinical Study Indicates Promising Solution to Treat Ulcerative Colitis Company's Patented...
Monday, September 19, 2016   (0 Comments - view/add)
Catalyst Pharmaceuticals Announces Publication of CPP-115 Clinical Efficacy Data for Infantile Spasm »
Catalyst Pharmaceuticals Announces Publication of CPP-115 Clinical Efficacy Data for Infantile Spasms in Epilepsy & Be...
Monday, August 29, 2016   (0 Comments - view/add)
FSU research team makes Zika drug breakthrough »
August 29, 2016   FSU research team makes Zika drug breakthrough   A team of researchers f...
Tuesday, August 23, 2016   (0 Comments - view/add)
Oragenics Selects New Lantibiotic for Further Development in Clostridium difficile Infections »
August 23, 2016   Oragenics Selects New Lantibiotic for Further Development in  Clostridium diffi...
Wednesday, August 3, 2016   (0 Comments - view/add)
HedgePath Pharmaceuticals Announces Positive Interim Data in its Phase II(b) Cancer Trial »
FOR IMMEDIATE RELEASE    HedgePath Pharmaceuticals Announces Positive Interim Data in its Phase II(b)...
Wednesday, July 6, 2016   (0 Comments - view/add)
Research from University of Miami and Tetra Discovery Shows Potential of Novel Drug to Improve... »
Research from University of Miami and Tetra Discovery Shows Potential of Novel Drug to Improve Memory after Traumatic Brai...
Tuesday, June 28, 2016   (0 Comments - view/add)
Biscayne Pharmaceuticals Presents Data On Novel Antiepileptic Agent BIS-001 AT EILAT Conference On.. »
MADRID and MIAMI BEACH, Fla. , June 28, 2016 /PRNewswire/ -- Biscayne Pharmaceuticals, Inc., today reported...
Thursday, June 9, 2016   (0 Comments - view/add)
First Type 1 Diabetes Patient in Europe is Free from Insulin Therapy after Undergoing Diabetes... »
First Type 1 Diabetes Patient in Europe is Free from Insulin Therapy after Undergoing Diabetes Research Institute's BioHub...
Tuesday, May 10, 2016   (0 Comments - view/add)
US Phytotherapy Successfully Tests a Viable Treatment for Zika Virus »
US Phytotherapy Successfully Tests a Viable Treatment for Zika Virus   ORLANDO, Fla., M...
Monday, May 2, 2016   (0 Comments - view/add)
Oragenics Announces Positive Results from Confirmatory Animal Study of AG013 for Treatment of Oral.. »
MAY 2, 2016   Oragenics Announces Positive Results from Confirmatory Animal Study of AG013 for Treatment o...
Thursday, April 21, 2016   (0 Comments - view/add)
Medtronic Launches New Endoscopic Ablation Catheter for Barrett's Esophagus »
Medtronic Launches New Endoscopic Ablation Catheter for Barrett's Esophagus Barrx TM 360 Express RFA Balloon C...
Thursday, April 21, 2016   (0 Comments - view/add)
TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Ketterin »
TapImmune Announces Phase 2 Ovarian Cancer Trial Study with AstraZeneca/MedImmune and Sloan Kettering Cancer Institute...
Monday, February 29, 2016   (0 Comments - view/add)
Scripps Florida Scientists Find Way to Predict Activity of Stem Cells »
Scripps Florida Scientists Find Way to Predict Activity of Stem Cells Method Could Help Evaluate Potential Stem Cell...
Monday, February 22, 2016   (0 Comments - view/add)
ARC Surgicals Manufacturing Receives Patent and FDA Approvals for Groundbreaking Device that... »
ARC Surgicals Manufacturing Receives Patent and FDA Approvals for Groundbreaking Device that Reduces Risks, Increases Pati...
Wednesday, January 20, 2016   (0 Comments - view/add)
AGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1... »
AGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Alpha-1 Antitrypsin (AAT) Deficie...
Friday, January 8, 2016   (0 Comments - view/add)
Nova Southeastern University Announces that its NSU Cell Therapy Institute Publishes Key Findings... »
Nova Southeastern University Announces that its NSU Cell Therapy Institute Publishes Key Findings in Three Leading Scienti...
Thursday, January 7, 2016   (0 Comments - view/add)
AGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of... »
AGTC Announces Preclinical Data Evaluating Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia and Other Reti...
Thursday, January 7, 2016   (0 Comments - view/add)
Applied Genetic (AGTC) Reports Early Data on Cone-Specific Promoters for Use in Gene Therapy of... »
Applied Genetic (AGTC) Reports Early Data on Cone-Specific Promoters for Use in Gene Therapy of Achromatopsia, Other Retin...
Wednesday, January 6, 2016   (0 Comments - view/add)
Sun BioPharma, Inc. Announces Dosing of First Patient in Phase 1 Clinical Study of SBP-101 for... »
January 6, 2016   Sun BioPharma, Inc. Announces Dosing of First Patient in Phase 1 Clinical Study of SBP-1...
Monday, November 23, 2015   (0 Comments - view/add)
AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat Achromatopsia »
Nov 23, 2015 PDF AGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Trea...
Thursday, November 5, 2015   (0 Comments - view/add)
Banyan Biomarkers Reports Successful Clinical Trial Results of Blood Test to Evaluate Mild and... »
Banyan Biomarkers Reports Successful Clinical Trial Results of Blood Test to Evaluate Mild and Moderate Traumatic Brain In...

Displaying page 26 of 27
 |<   <<   <  21  |  22  |  23  |  24  |  25  |  26  |  27

About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 8,600 establishments and research organizations in the BioPharma, MedTech, Digital Health and Health Systems that collectively employ nearly 107,000 Floridians. Source: TEConomy/BIO (released 2022)